Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Edonerpic - FUJIFILM Toyama Chemical

Drug Profile

Edonerpic - FUJIFILM Toyama Chemical

Alternative Names: Edonerpic maleate - FUJIFILM Toyama Chemical; T-817 MA

Latest Information Update: 13 Aug 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Toyama Chemical
  • Developer FUJIFILM Toyama Chemical; Toyama Chemical
  • Class Antidementias; Neuroprotectants; Small molecules; Vascular disorder therapies
  • Mechanism of Action Amyloid beta-protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Alzheimer's disease; Stroke

Most Recent Events

  • 06 Aug 2019 Phase-II clinical trials in Stroke in Japan (PO)
  • 06 May 2019 Phase-II clinical trials in Alzheimer's disease in Netherlands (PO) (EudraCT2018-003567-66)
  • 19 Jul 2017 Efficacy data from a phase II trial in Alzheimer's disease released by FUJIFILM
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top